Affinage · Plasmodium

JmjC1

PF3D7_0809900 · JmjC domain-containing protein 1, putative

Annotated
2026-09-08
14 papers in source corpus 7 papers cited in narrative 7 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PF3D7_0809900 (JmjC1) is a predicted JmjC-domain histone lysine demethylase of P. falciparum that conserves the iron- and 2-oxoglutarate-binding and substrate-binding residues characteristic of the mammalian Jumonji enzyme family (PMID:18299133, PMID:32272012). It is one of three JmjC-domain proteins in the parasite, and pharmacological inhibition of the P. falciparum Jumonji demethylases as a group with pan-JmjC inhibitors killed asexual blood-stage parasites and blocked gametocyte development, accompanied by increased trimethylated histone lysine marks consistent with loss of demethylase activity (PMID:32272012). Comparative genomics places JmjC1 in primate and avian malaria parasites (P. falciparum, P. vivax, P. knowlesi, P. gallinaceum) but not in rodent malaria parasites, an evolutionary distribution linked to its functional coupling with PfSET2-deposited H3K36me3 (PMID:24391504, PMID:34238209). Its own locus is repressed in stage II gametocytes through stage-specific H3K36me2/3 enrichment upstream of the transcription start site, integrating JmjC1 into the H3K36-methylation regulatory circuit during early gametocyte development (PMID:33794978). Direct in vitro enzymatic characterization of JmjC1 specifically — including biochemical confirmation of its substrate specificity — has not been reported in the available corpus; catalytic activity was demonstrated for the sibling PfJmj3, not for JmjC1 (PMID:32272012).

Mechanistic history

Synthesis pass · year-by-year structured walk · 6 steps
  1. 2008 Low

    The question of whether P. falciparum encodes enzymes capable of removing histone lysine methylation was first addressed by identifying JmjC1 as a candidate JmjC-domain demethylase, establishing that active histone demethylation was plausible in the parasite.

    Evidence Bioinformatic/phylogenetic analysis of the P. falciparum genome; no direct enzymatic assay of JmjC1 performed

    PMID:18299133

    Open questions at the time
    • Computational prediction only; no in vitro demethylase assay of JmjC1
    • No substrate identified experimentally
    • No cellular localization or expression data
  2. 2014 Low

    To connect JmjC1 to a defined chromatin pathway, comparative genomics proposed it as the cognate demethylase counteracting PfSET2-deposited H3K36me3 and showed it is restricted to primate malaria parasites, implicating it in var gene regulation.

    Evidence Comparative genomics across six Plasmodium species; functional link to PfSET2/H3K36me3 inferred from orthology, not direct assay of JmjC1

    PMID:24391504

    Open questions at the time
    • Enzyme-substrate link to H3K36me3 inferred from orthology, not demonstrated for JmjC1
    • No loss-of-function evidence for a role in var gene regulation
    • Functional consequence of primate-specific distribution untested
  3. 2020 Medium

    Whether the parasite Jumonji enzymes are catalytically competent and druggable was tested; JmjC1 was shown to conserve the catalytic iron/2-OG residues, and pan-JmjC inhibition killed asexual parasites and blocked gametocytes with rising histone trimethylation, though direct catalysis was proven only for the sibling PfJmj3.

    Evidence Sequence alignment for JmjC1 catalytic residues; asexual growth (3D7, Dd2) and gametocyte assays with pan-JmjC inhibitors; histone trimethylation immunoassay; in vitro 2-OG-to-succinate assay of PfJmj3 only

    PMID:32272012

    Open questions at the time
    • JmjC1-specific enzymatic activity not directly measured; catalysis shown for PfJmj3 only
    • Inhibitor phenotypes apply to the JmjC family collectively, not JmjC1 alone
    • No genetic knockout to attribute phenotypes to JmjC1
  4. 2021 Medium

    How JmjC1 itself is regulated across the life cycle was addressed by mapping histone marks at its locus, revealing stage II gametocyte-specific H3K36me2/3 enrichment upstream of its TSS correlating with transcriptional repression, embedding JmjC1 within a self-referential H3K36 regulatory circuit.

    Evidence ChIP-seq for H3K36me2/me3 in stage-specific gametocytes correlated with expression data

    PMID:33794978

    Open questions at the time
    • Repression inferred from mark association, not confirmed by loss-of-function
    • Mechanism depositing H3K36me2/3 at jmjc1 not defined
    • Functional consequence of jmjc1 repression for gametocytes untested
  5. 2021 Low

    The evolutionary breadth of JmjC1 was refined by synteny analysis showing conservation across Laverania, P. vivax, and the avian parasite P. gallinaceum but loss in rodent parasites, arguing its origin predates the Plasmodium root and its functions extend beyond var gene regulation.

    Evidence Comparative genomic synteny analysis across Plasmodium species and Laverania members

    PMID:34238209

    Open questions at the time
    • Comparative genomics only; no functional experiment
    • Additional (non-var) functions proposed but not defined
    • No mechanistic basis for loss in rodent parasites
  6. 2022 Low

    Reviews consolidated JmjC1's presumed substrate specificity, citing prior work that it acts on H3K9me2/3 and H3K36me3 and grouping it with the JMJD/KDM4-related demethylases to rationalize antimalarial inhibitor design, without adding new experimental evidence on JmjC1.

    Evidence Substrate specificity cited from prior literature in review and medicinal-chemistry contexts; no new experiment on JmjC1

    PMID:35433676 PMID:36106425

    Open questions at the time
    • Substrate specificity attributed to cited studies, not independently demonstrated in this corpus
    • No structural model of JmjC1
    • No direct enzyme kinetics or inhibitor selectivity data for JmjC1

Open questions

Synthesis pass · forward-looking unresolved questions
  • The central open question is direct biochemical demonstration of JmjC1's own demethylase activity and substrate specificity, and genetic dissection of its role in var gene regulation and gametocyte development independent of its sibling Jumonji enzymes.
  • No purified-enzyme demethylase assay for JmjC1
  • No JmjC1-specific loss-of-function phenotype
  • No structure or defined interaction partners for JmjC1

Mechanism profile

Synthesis pass · controlled-vocabulary classification

Evidence

Reading pass · 7 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2008 JmjC1 (PF3D7_0809900) was identified by bioinformatic analysis as a JmjC-domain-containing protein in P. falciparum, predicted to function as a histone lysine demethylase capable of reversing trimethylated lysine residues, analogous to the JmjC-domain demethylase family in other eukaryotes. Bioinformatic/phylogenetic analysis of P. falciparum genome; no direct enzymatic assay of JmjC1 itself was reported International journal for parasitology Low 18299133
2014 JmjC1 (PF3D7_0809900) was identified as the cognate demethylase of PfSET2, predicted to remove H3K36me3 marks deposited by PfSET2. Comparative genomic analysis showed JmjC1 is present in primate malaria parasites (P. falciparum, P. vivax, P. knowlesi) but absent from rodent malaria parasite genomes (P. berghei, P. yoelii, P. chabaudi), suggesting it is specific to primate parasites and functionally linked to PfSET2-mediated var gene regulation. Comparative genomics across six Plasmodium species; functional link to PfSET2 and H3K36me3 inferred from orthology, not direct enzymatic assay of JmjC1 PLoS pathogens Low 24391504
2020 JmjC1 (PF3D7_0809900) is one of three JmjC-domain-containing proteins in P. falciparum (alongside PfJmjC2 and PfJmj3). Residues required for iron and 2-oxoglutarate (2-OG) binding and substrate binding in mammalian Jumonji enzymes are conserved in PfJmjC1. Pharmacological inhibition of P. falciparum Jumonji demethylases with pan-JmjC inhibitors (JIB-04, GSK-J4, ML324, SD-70) killed asexual blood stage parasites and blocked gametocyte development, with increased trimethylated lysine marks on histones in late-stage parasites consistent with demethylase inhibition. PfJmj3 (not PfJmjC1) was directly demonstrated to convert 2-oxoglutarate to succinate in an iron-dependent manner, and this activity was inhibited by JIB-04. Sequence alignment (conservation of catalytic residues); asexual parasite growth inhibition assay (3D7, Dd2); gametocyte/gamete formation assay; histone trimethylation immunoassay; in vitro enzymatic assay of PfJmj3 catalytic activity (2-OG to succinate conversion) ACS infectious diseases Medium 32272012
2021 In stage II gametocytes, the jmjc1 locus (PF3D7_0809900) is enriched for H3K36me2 and H3K36me3 upstream of the transcription start site, a pattern not seen in pre- or post-stage II gametocytes, correlating with transcriptional repression of jmjc1 at this stage. This H3K36me2&3-mediated repression of jmjc1 was proposed as a mechanism to safeguard the integrity of H3K36 methylation and associated transcriptional repression during early gametocyte development. Chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) for H3K36me2 and H3K36me3 in stage-specific gametocytes; correlation with gene expression data Epigenetics & chromatin Medium 33794978
2022 PfJmjC1 (PF3D7_0809900) is reported to be active on H3K9me2/3 and H3K36me3 substrates, while PfJmj3 is specific for H3K36me3. This substrate specificity is cited from prior literature (Matthews et al., 2020 and Cui et al., 2008a) in a review context. Cited from prior literature in a review; not a new direct experiment in this paper Frontiers in cell and developmental biology Low 35433676
2022 PfJmjC1 (PF3D7_0809900) is reported to be active on H3K9me2/3 and also H3K36me3, placing it in the JMJD/KDM4-related class of demethylases. This specificity is cited as an established property and used to rationalize inhibitor design targeting Plasmodium JmjC enzymes as structurally distinct from human KDM4B. Cited prior experimental data in the context of a medicinal chemistry study; no new direct experiment on JmjC1 performed Chembiochem : a European journal of chemical biology Low 36106425
2021 JmjC1 (PF3D7_0809900) has syntenic orthologs throughout the Laverania subgenus and also in P. vivax and the bird parasite P. gallinaceum, but is absent from rodent malaria parasite genomes, suggesting its origin predates the root of the Plasmodium genus and that its functions are not restricted to var gene regulation. Comparative genomic synteny analysis across Plasmodium species and Laverania subgenus members BMC ecology and evolution Low 34238209

Source papers

Stage 0 corpus · 14 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2008 Histone lysine methyltransferases and demethylases in Plasmodium falciparum. International journal for parasitology 106 18299133
2026 Global-scale population genetic analysis of Plasmodium falciparum identifies region-specific patterns of malaria parasite adaptation. Nature communications 0 42115185
2024 Epigenetic regulation as a therapeutic target in the malaria parasite Plasmodium falciparum. Malaria journal 0 38347549
2024 Genomic analysis of global Plasmodium vivax populations reveals insights into the evolution of drug resistance. Nature communications 0 39738010
2023 Isoliensinine from Cissampelos pariera rhizomes exhibits potential gametocytocidal and anti-malarial activities against Plasmodium falciparum clinical isolates. Malaria journal 0 37208735
2022 Histone Modification Landscapes as a Roadmap for Malaria Parasite Development. Frontiers in cell and developmental biology 0 35433676
2022 New Transmission-Selective Antimalarial Agents through Hit-to-Lead Optimization of 2-([1,1'-Biphenyl]-4-carboxamido)benzoic Acid Derivatives. Chembiochem : a European journal of chemical biology 0 36106425
2021 H3K36 methylation reprograms gene expression to drive early gametocyte development in Plasmodium falciparum. Epigenetics & chromatin 0 33794978
2021 Evolution of transcriptional control of antigenic variation and virulence in human and ape malaria parasites. BMC ecology and evolution 0 34238209
2020 Disruption of the Plasmodium falciparum Life Cycle through Transcriptional Reprogramming by Inhibitors of Jumonji Demethylases. ACS infectious diseases 0 32272012
2019 The G9a Histone Methyltransferase Inhibitor BIX-01294 Modulates Gene Expression during Plasmodium falciparum Gametocyte Development and Transmission. International journal of molecular sciences 0 31615031
2019 Genome-Wide Analysis of Genetic Diversity in Plasmodium falciparum Isolates From China-Myanmar Border. Frontiers in genetics 0 31737048
2014 Recruitment of PfSET2 by RNA polymerase II to variant antigen encoding loci contributes to antigenic variation in P. falciparum. PLoS pathogens 0 24391504
2013 Horizontal gene transfer of epigenetic machinery and evolution of parasitism in the malaria parasite Plasmodium falciparum and other apicomplexans. BMC evolutionary biology 0 23398820